BioSpace News Archive

Business

Heidelberg Pharma AG and Advanced Proteome Therapeutics Progress Collaborative Program

The companies have agreed to test the combination of APC’s proprietary site-selective protein modification technology and Heidelberg Pharma’s proprietary ATAC technology in order to generate superior cancer therapeutics.

January 9, 2018
·
4 min read
Drug Development

FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase III Study

The Company’s PLX-PAD program has already been selected for accelerated approval pathways in both regions, including the FDA’s Fast Track Designation and the EMA Adaptive Pathways program.

January 9, 2018
·
5 min read
Business

Genetic Technologies Regains Nasdaq Listing Compliance

The Notice confirms that the Nasdaq Listing Rules deficiency notice of July 19, 2017, has been remedied and that the matter is now closed.

January 9, 2018
·
2 min read
Drug Development

Publication Authored by Researchers at Selecta Biosciences and the National Cancer Institute in PNAS Discusses Restoration of Anti-Tumor Activity of Recombinant Immunotoxin LMB-100 When Combined With SVP-Rapamycin

In the PNAS publication, the authors described preclinical work in which SVP-Rapamycin mitigated the formation of inhibitory ADAs to LMB-100 in both naïve mice and mice pre-exposed to LMB-100, resulting in restoration of LMB-100’s anti-tumor activity.

January 9, 2018
·
5 min read
Drug Development

Pain Therapeutics Surges on Positive Clinical Study Data

All study subjects reported reduced ‘Drug Liking’ ‘Take Drug Again’ and ‘Drug High’ for REMOXY compared to oxycodone IR.

January 9, 2018
·
5 min read
Quotient Limited Reports Further Positive Data on its Initial Disease Screening Microarray and Provides Update on Blood Grouping

A summary of the latest performance evaluation data generated during process validation for the MosaiQ SDS Microarray (to detect CMV and Syphilis) is set out below:

January 9, 2018
·
5 min read
Business

DCN Dx Appoints John L. Tonkinson, Ph.D. as Chief Business Development Officer

DCN Dx announced today that John L. Tonkinson, Ph.D. has joined the company in the newly created role of Chief Business Development Officer.

January 9, 2018
·
2 min read
Vital Moto Mod Offers First Integrated Vital Signs Monitoring Platform to Accurately Measure Five (5) Vital Signs, Including Systolic and Diastolic Blood Pressure, From Your Finger.

Vital USA in partnership with Lenovo and Motorola, announced today at CES the release of the Vital Moto Mod.

January 9, 2018
·
2 min read
Policy

InflaRx Receives IND Acceptance To Proceed With A Phase IIb Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa

The open IND will allow InflaRx to conduct a phase IIb study to determine efficacy and safety of IFX-1, a first-in-class anti-human complement factor C5a antibody, in patients with moderate or severe Hidradenitis Suppurativa.

January 9, 2018
·
4 min read
Business

WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity

The first phase of the partnership involved mining WuXi NextCODE’s knowledgebase of all major reference datasets to identify all rare sequence variants in the POMC, PCSK1, and LEPR genes in the MC4R pathway.

January 9, 2018
·
4 min read